The molecular basis and potential role of survivin in cancer diagnosis and therapy

Hengartner, 2000, The biochemistry of apoptosis, Nature, 407, 770, 10.1038/35037710 Reed, 1999, Dysregulation of apoptosis in cancer, J. Clin. Oncol., 17, 2941, 10.1200/JCO.1999.17.9.2941 Nicholson, 2000, From bench to clinic with apoptosis-based therapeutic agents, Nature, 407, 810, 10.1038/35037747 Ambrosini, 1997, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat. Med., 3, 917, 10.1038/nm0897-917 Deveraux, 1999, IAP family proteins – suppressors of apoptosis, Genes Dev., 13, 239, 10.1101/gad.13.3.239 Verdecia, 2000, Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement, Nat. Struct. Biol., 7, 602, 10.1038/77929 Li, 1998, Control of apoptosis and mitotic spindle checkpoint by survivin, Nature, 396, 580, 10.1038/25141 Li, 1999, The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression, Cancer Res., 59, 3143 Kobayashi, 1999, Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation, Proc. Natl. Acad. Sci. U. S. A., 96, 1457, 10.1073/pnas.96.4.1457 Zhao, 2000, The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner, J. Cell Sci., 113, 4363, 10.1242/jcs.113.23.4363 Skoufias, 2000, Human survivin is a kinetochore-associated passenger protein, J. Cell Biol., 151, 1575, 10.1083/jcb.151.7.1575 Uren, 2000, Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype, Curr. Biol., 10, 1319, 10.1016/S0960-9822(00)00769-7 Wheatley, 2001, INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis, Curr. Biol., 11, 886, 10.1016/S0960-9822(01)00238-X Fortugno, P. et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J.Cell Sci. (in press) Tamm, 1998, IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs, Cancer Res., 58, 5315 Mahotka, 1999, Survivin-ΔEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different anti-apoptotic properties, Cancer Res., 59, 6097 Suzuki, 2000, Survivin initiates procaspase 3–p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death, Oncogene, 19, 1346, 10.1038/sj.onc.1203429 Islam, 2000, High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma, Oncogene, 19, 617, 10.1038/sj.onc.1203358 Kasof, 2000, Livin, a novel inhibitor-of-apoptosis (IAP) family member, J. Biol. Chem., 276, 3238, 10.1074/jbc.M003670200 Grossman, 2001, Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53, J. Clin. Invest., 108, 991, 10.1172/JCI13345 Ambrosini, 1998, Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting, J. Biol. Chem., 273, 11177, 10.1074/jbc.273.18.11177 Grossman, 1999, Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma, J. Invest. Dermatol., 113, 1076, 10.1046/j.1523-1747.1999.00776.x Chen, 2000, Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth, Neoplasia, 2, 235, 10.1038/sj.neo.7900091 Olie, 2000, A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy, Cancer Res., 60, 2805 Jones, 2000, Deterin, a new inhibitor of apoptosis from Drosophila melanogaster, J. Biol. Chem., 275, 22157, 10.1074/jbc.M000369200 Du, 2000, Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition, Cell, 102, 33, 10.1016/S0092-8674(00)00008-8 Shin, 2001, An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7, Biochemistry, 40, 1117, 10.1021/bi001603q Huang, 2001, Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain, Cell, 104, 781, 10.1016/S0092-8674(02)02075-5 Li, 1999, Pleiotropic cell-division defects and apoptosis induced by interference with survivin function, Nat. Cell Biol., 1, 461, 10.1038/70242 Uren, 1999, Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division, Proc. Natl. Acad. Sci. U. S. A., 96, 10170, 10.1073/pnas.96.18.10170 Speliotes, 2000, The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone, Mol. Cell, 6, 211, 10.1016/S1097-2765(00)00023-X Li, 2000, Cell division regulation by BIR1, a member of the inhibitor of apoptosis family in yeast, J. Biol. Chem., 275, 6707, 10.1074/jbc.275.10.6707 Kallio, M. et al. Human inhibitor of apoptosis (IAP) protein survivin participates in regulation of chromosome segregation and mitotic exit. FASEB J. (in press) Adida, 1998, Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation, Am. J. Pathol., 152, 43 Carter, 2001, Cytokine-regulated expression of survivin in myeloid leukemia, Blood, 97, 2784, 10.1182/blood.V97.9.2784 Gianani, 2001, Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa, Hum. Pathol., 32, 119, 10.1053/hupa.2001.21897 Grossman, 1999, Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line, Lab. Invest., 79, 1121 Monzo, 1999, A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers, J. Clin. Oncol., 17, 2100, 10.1200/JCO.1999.17.7.2100 Tanaka, 2000, Expression of survivin and its relationship to loss of apoptosis in breast carcinomas, Clin. Cancer Res., 6, 127 Kawasaki, 1998, Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer, Cancer Res., 58, 5071 Lu, 1998, Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas, Cancer Res., 58, 1808 Kato, 2001, Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy, Int. J.Cancer, 95, 92, 10.1002/1097-0215(20010320)95:2<92::AID-IJC1016>3.0.CO;2-9 Satoh, 2001, Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors, Cancer, 92, 271, 10.1002/1097-0142(20010715)92:2<271::AID-CNCR1319>3.0.CO;2-0 Swana, 1999, Tumor content of the anti-apoptosis molecule survivin and recurrence of bladder cancer, New Engl. J. Med., 341, 452, 10.1056/NEJM199908053410614 Saitoh, 1999, Analysis of Bcl-2, Bax and Survivin genes in uterine cancer, Int. J. Oncol., 15, 137 Yoshida, 2001, Survivin, Bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas, Int. J. Oncol., 19, 537 Adida, 2000, Prognostic significance of survivin expression in diffuse large B-cell lymphomas, Blood, 96, 1921 Adida, 2000, Expression and prognostic significance of survivin in de novo acute myeloid leukaemia, Br. J. Haematol., 111, 196, 10.1046/j.1365-2141.2000.02328.x Kamihira, 2001, Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis, Br. J. Haematol., 114, 63, 10.1046/j.1365-2141.2001.02902.x Adida, 1998, Anti-apoptosis gene, survivin, and prognosis of neuroblastoma, Lancet, 351, 882, 10.1016/S0140-6736(05)70294-4 Velculescu, 1999, Analysis of human transcriptomes, Nat. Genet., 23, 387, 10.1038/70487 Plantaz, 1997, Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization, Am. J. Pathol., 150, 81 Hattori, 2001, DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes, Cancer Lett., 169, 155, 10.1016/S0304-3835(01)00499-2 Sarela, 2001, Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas, Ann. Surg. Oncol., 8, 305, 10.1007/s10434-001-0305-0 Rohayem, 2000, Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients, Cancer Res., 60, 1815 Schmitz, 2000, Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides, Cancer Res., 60, 4845 Andersen, 2001, Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients, Cancer Res., 61, 869 Smith, 2001, Urine detection of survivin and diagnosis of bladder cancer, J. Am. Med. Assoc., 285, 324, 10.1001/jama.285.3.324 O'Connor, 2000, Regulation of apoptosis at cell division by p34cdc[2] phosphorylation of survivin, Proc. Natl. Acad. Sci. U. S. A., 97, 13103, 10.1073/pnas.240390697 Grossman, 2001, Inhibition of melanoma tumor growth in vivo by survivin targeting, Proc. Natl. Acad. Sci. U. S. A., 98, 635, 10.1073/pnas.230450097 Mesri, 2001, Cancer gene therapy using a survivin mutant adenovirus, J. Clin. Invest., 108, 981, 10.1172/JCI200112983 Senderowicz, 1998, Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms, J. Clin. Oncol., 16, 2986, 10.1200/JCO.1998.16.9.2986 O'Connor, 2000, Control of apoptosis during angiogenesis by survivin expression in endothelial cells, Am. J. Pathol., 156, 393, 10.1016/S0002-9440(10)64742-6 Tran, 1999, Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells, Biochem. Biophys. Res. Commun., 264, 781, 10.1006/bbrc.1999.1589 Papapetropoulos, 2000, Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway, J. Biol. Chem., 275, 9102, 10.1074/jbc.275.13.9102 Mesri, 2001, Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting, Am. J.Pathol., 158, 1757, 10.1016/S0002-9440(10)64131-4